MPM BioVentures 2014, L.P. 13D and 13G filings for Werewolf Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-05-14 5:18 pm Purchase |
2021-05-04 | 13D | Werewolf Therapeutics, Inc. HOWL |
MPM BioVentures 2014, L.P. | 6,731,087 24.400% |
6,731,087 (New Position) |
Filing |